IRD · Categories · Coverage

IRD - Analyst coverage initiated

Opus Genetics Inc. (IRD) analyst coverage initiated - real-time wire coverage filtered to Coverage only.

Recent Coverage for IRD

• 1d
  Guggenheim initiated coverage on Opus Genetics with a new price target

  Guggenheim initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $16.00
• 15d
  Leerink Partners initiated coverage on Opus Genetics with a new price target

  Leerink Partners initiated coverage of Opus Genetics with a rating of Outperform and set a new price target of $10.00
• 38d
  Citizens initiated coverage on Opus Genetics with a new price target

  Citizens initiated coverage of Opus Genetics with a rating of Mkt Perform and set a new price target of $12.00
• 67d
  Cantor Fitzgerald initiated coverage on Opus Genetics with a new price target

  Cantor Fitzgerald initiated coverage of Opus Genetics with a rating of Overweight and set a new price target of $15.00
• 81d
  Oppenheimer initiated coverage on Opus Genetics with a new price target

  Oppenheimer initiated coverage of Opus Genetics with a rating of Outperform and set a new price target of $10.00
• 136d
  BTIG Research initiated coverage on Opus Genetics with a new price target

  BTIG Research initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $7.00
• 177d
  B. Riley Securities initiated coverage on Opus Genetics with a new price target

  B. Riley Securities initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $9.00
• 192d
  Piper Sandler initiated coverage on Opus Genetics with a new price target

  Piper Sandler initiated coverage of Opus Genetics with a rating of Overweight and set a new price target of $7.00
• 219d
  Wedbush initiated coverage on Opus Genetics with a new price target

  Wedbush initiated coverage of Opus Genetics with a rating of Outperform and set a new price target of $8.00
• 232d
  Chardan Capital Markets initiated coverage on Opus Genetics with a new price target

  Chardan Capital Markets initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $9.00
• 420d
  Craig Hallum initiated coverage on Opus Genetics with a new price target

  Craig Hallum initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $6.00

Other IRD categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings